These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 38634685)

  • 61. Hepatic Venous Pressure Gradient Predicts Long-Term Mortality in Patients with Decompensated Cirrhosis.
    Kim TY; Lee JG; Sohn JH; Kim JY; Kim SM; Kim J; Jeong WK
    Yonsei Med J; 2016 Jan; 57(1):138-45. PubMed ID: 26632394
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Preventing the development of varices in cirrhosis.
    Garcia-Tsao G
    J Clin Gastroenterol; 2007; 41 Suppl 3():S300-4. PubMed ID: 17975480
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Management of Liver Decompensation in Advanced Chronic Liver Disease: Ascites, Hyponatremia, and Gastroesophageal Variceal Bleeding.
    Baiges A; Hernández-Gea V
    Clin Drug Investig; 2022 Jun; 42(Suppl 1):25-31. PubMed ID: 35476218
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Nonselective β blockers increase risk for hepatorenal syndrome and death in patients with cirrhosis and spontaneous bacterial peritonitis.
    Mandorfer M; Bota S; Schwabl P; Bucsics T; Pfisterer N; Kruzik M; Hagmann M; Blacky A; Ferlitsch A; Sieghart W; Trauner M; Peck-Radosavljevic M; Reiberger T
    Gastroenterology; 2014 Jun; 146(7):1680-90.e1. PubMed ID: 24631577
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Beta-blockers and cirrhosis: Striking the right balance.
    Cromer M; Wilcox CM; Shoreibah M
    Am J Med Sci; 2024 Apr; 367(4):228-234. PubMed ID: 38262558
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Patients with liver cirrhosis show worse survival if decompensation occurs later during course of disease than at diagnosis.
    Nilsson E; Anderson H; Sargenti K; Lindgren S; Prytz H
    Scand J Gastroenterol; 2018 Apr; 53(4):475-481. PubMed ID: 29513096
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Morbidity and mortality after transjugular intrahepatic portosystemic shunt placement in patients with cirrhosis.
    Dissegna D; Sponza M; Falleti E; Fabris C; Vit A; Angeli P; Piano S; Cussigh A; Cmet S; Toniutto P
    Eur J Gastroenterol Hepatol; 2019 May; 31(5):626-632. PubMed ID: 30550458
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Hemodynamic Response to Carvedilol is Maintained for Long Periods and Leads to Better Clinical Outcome in Cirrhosis: A Prospective Study.
    Kirnake V; Arora A; Gupta V; Sharma P; Singla V; Bansal N; Goyal M; Chawlani R; Kumar A
    J Clin Exp Hepatol; 2016 Sep; 6(3):175-185. PubMed ID: 27746613
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Hepatic venous pressure gradient measurement in patients with liver cirrhosis: a correlation with disease severity and variceal bleeding.
    Silkauskaite V; Pranculis A; Mitraite D; Jonaitis L; Petrenkiene V; Kupcinskas L
    Medicina (Kaunas); 2009; 45(1):8-13. PubMed ID: 19223700
    [TBL] [Abstract][Full Text] [Related]  

  • 70. 5-MTHF enhances the portal pressure reduction achieved with propranolol in patients with cirrhosis: A randomized placebo-controlled trial.
    Vukotic R; Di Donato R; Roncarati G; Simoni P; Renzulli M; Gitto S; Schepis F; Villa E; Berzigotti A; Bosch J; Andreone P
    J Hepatol; 2023 Oct; 79(4):977-988. PubMed ID: 37482222
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Beta-Blockers Lower First Decompensation in Patients With Cirrhosis and Enduring Portal Hypertension After Etiological Treatment.
    Turco L; Taru MG; Vitale G; Stefanescu H; Mirici Cappa F; Berardi S; Baldan A; Di Donato R; Pianta P; Vero V; Vizioli L; Procopciuc LM; Procopet B; Morelli MC; Piscaglia F
    Clin Gastroenterol Hepatol; 2024 Aug; ():. PubMed ID: 39209198
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Beta-blockers or Placebo for Primary Prophylaxis (BOPPP) of oesophageal varices: study protocol for a randomised controlled trial.
    Patel VC; McPhail MJ; Uddin R; Jafari H; Lawrence V; Le Boutillier C; Shearer J; Yaziji N; Cape A; Ahmed H; Ward C; Walsh P; Besly K; Zamalloa A; Kelly J; ; Carter B
    Trials; 2024 Apr; 25(1):265. PubMed ID: 38627804
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Long-term results of a clinical trial of nadolol with or without isosorbide mononitrate for primary prophylaxis of variceal bleeding in cirrhosis.
    Merkel C; Marin R; Sacerdoti D; Donada C; Cavallarin G; Torboli P; Amodio P; Sebastianelli G; Bolognesi M; Felder M; Mazzaro C; Gatta A
    Hepatology; 2000 Feb; 31(2):324-9. PubMed ID: 10655253
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Hemodynamic Effects of Adding Simvastatin to Carvedilol for Primary Prophylaxis of Variceal Bleeding: A Randomized Controlled Trial.
    Vijayaraghavan R; Jindal A; Arora V; Choudhary A; Kumar G; Sarin SK
    Am J Gastroenterol; 2020 May; 115(5):729-737. PubMed ID: 32079861
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis.
    Groszmann RJ; Garcia-Tsao G; Bosch J; Grace ND; Burroughs AK; Planas R; Escorsell A; Garcia-Pagan JC; Patch D; Matloff DS; Gao H; Makuch R;
    N Engl J Med; 2005 Nov; 353(21):2254-61. PubMed ID: 16306522
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Systemic inflammation increases across distinct stages of advanced chronic liver disease and correlates with decompensation and mortality.
    Costa D; Simbrunner B; Jachs M; Hartl L; Bauer D; Paternostro R; Schwabl P; Scheiner B; Stättermayer AF; Pinter M; Trauner M; Mandorfer M; Reiberger T
    J Hepatol; 2021 Apr; 74(4):819-828. PubMed ID: 33075344
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Editorial: Beta-blockers and the prevention of decompensation in cirrhosis: worth the trouble.
    Northup PG; Henry ZH
    Am J Gastroenterol; 2012 Mar; 107(3):428-30. PubMed ID: 22388023
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Midodrine plus propranolol versus propranolol alone in preventing first bleed in patients with cirrhosis and severe ascites: a randomized controlled trial.
    Ranjan A; Jindal A; Maiwall R; Vashishtha C; Vijayaraghavan R; Arora V; Sarin SK
    Hepatol Int; 2024 Aug; 18(4):1261-1270. PubMed ID: 38727780
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Early identification of haemodynamic response to pharmacotherapy is essential for primary prophylaxis of variceal bleeding in patients with 'high-risk' varices.
    Sharma P; Kumar A; Sharma BC; Sarin SK
    Aliment Pharmacol Ther; 2009 Jul; 30(1):48-60. PubMed ID: 19392862
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Complications of cirrhosis. I. Portal hypertension.
    Bosch J; García-Pagán JC
    J Hepatol; 2000; 32(1 Suppl):141-56. PubMed ID: 10728801
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.